SAB Biotherapeutics Inc. (SABS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.08

1.24%

After-hours Dec 13, 2024, 04:00 PM EST

SAB Biotherapeutics Inc. Forcast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for SABS stock have an median target of 9.5, with a low estimate of 6 and a high estimate of 12. The median target predicts an increase of 135.73% from the current stock price of 4.03.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6	$9.25	$9.5	$12
Change	48.88%	129.53%	135.73%	197.77%

AI Analyst Report

Chardan Capital has reaffirmed its Buy rating for ... Unlock content with Pro Subscription

Updated Nov 07, 2024

Rating	May 24	Jun 24	Aug 24	Sep 24	Oct 24	Nov 24
Strong Buy	0	0	0	0	0	0
Buy	2	1	3	2	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	1	3	2	1	1

Financial Forecast this Year

Revenue This Year

1.44M

from 2.24M

-35.6%

from 2.24M

Revenue Next Year

800.00K

from 1.44M

-44.5%

from 1.44M

EPS This Year

-3.6

from -7.64

52.9%

from -7.64

EPS Next Year

-2.97

from -3.6

17.5%

from -3.6